317 related articles for article (PubMed ID: 12954054)
1. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
Johansson E; Parkinson GN; Denny WA; Neidle S
J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
[TBL] [Abstract][Full Text] [Related]
2. Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.
Anlezark GM; Melton RG; Sherwood RF; Wilson WR; Denny WA; Palmer BD; Knox RJ; Friedlos F; Williams A
Biochem Pharmacol; 1995 Aug; 50(5):609-18. PubMed ID: 7669063
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase.
Atwell GJ; Boyd M; Palmer BD; Anderson RF; Pullen SM; Wilson WR; Denny WA
Anticancer Drug Des; 1996 Oct; 11(7):553-67. PubMed ID: 8921936
[TBL] [Abstract][Full Text] [Related]
4. An unusually cold active nitroreductase for prodrug activations.
Çelik A; Yetiş G
Bioorg Med Chem; 2012 Jun; 20(11):3540-50. PubMed ID: 22546205
[TBL] [Abstract][Full Text] [Related]
5. Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapy.
Friedlos F; Denny WA; Palmer BD; Springer CJ
J Med Chem; 1997 Apr; 40(8):1270-5. PubMed ID: 9111301
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel nitroreductases from Bacillus cereus and their interaction with the CB1954 prodrug.
Gwenin VV; Poornima P; Halliwell J; Ball P; Robinson G; Gwenin CD
Biochem Pharmacol; 2015 Dec; 98(3):392-402. PubMed ID: 26415543
[TBL] [Abstract][Full Text] [Related]
7. Nitro reduction as an electronic switch for bioreductive drug activation.
Siim BG; Denny WA; Wilson WR
Oncol Res; 1997; 9(6-7):357-69. PubMed ID: 9406242
[TBL] [Abstract][Full Text] [Related]
8. Virtual cofactors for an Escherichia coli nitroreductase enzyme: relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT).
Knox RJ; Friedlos F; Jarman M; Davies LC; Goddard P; Anlezark GM; Melton RG; Sherwood RF
Biochem Pharmacol; 1995 May; 49(11):1641-7. PubMed ID: 7786305
[TBL] [Abstract][Full Text] [Related]
9. Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.
Prosser GA; Copp JN; Mowday AM; Guise CP; Syddall SP; Williams EM; Horvat CN; Swe PM; Ashoorzadeh A; Denny WA; Smaill JB; Patterson AV; Ackerley DF
Biochem Pharmacol; 2013 Apr; 85(8):1091-103. PubMed ID: 23399641
[TBL] [Abstract][Full Text] [Related]
10. New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide link.
Dowell RI; Springer CJ; Davies DH; Hadley EM; Burke PJ; Boyle FT; Melton RG; Connors TA; Blakey DC; Mauger AB
J Med Chem; 1996 Mar; 39(5):1100-5. PubMed ID: 8676345
[TBL] [Abstract][Full Text] [Related]
11. Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy.
Bailey SM; Knox RJ; Hobbs SM; Jenkins TC; Mauger AB; Melton RG; Burke PJ; Connors TA; Hart IR
Gene Ther; 1996 Dec; 3(12):1143-50. PubMed ID: 8986441
[TBL] [Abstract][Full Text] [Related]
12. 1.8 A crystal structure of the major NAD(P)H:FMN oxidoreductase of a bioluminescent bacterium, Vibrio fischeri: overall structure, cofactor and substrate-analog binding, and comparison with related flavoproteins.
Koike H; Sasaki H; Kobori T; Zenno S; Saigo K; Murphy ME; Adman ET; Tanokura M
J Mol Biol; 1998 Jul; 280(2):259-73. PubMed ID: 9654450
[TBL] [Abstract][Full Text] [Related]
13. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--I. Purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT).
Anlezark GM; Melton RG; Sherwood RF; Coles B; Friedlos F; Knox RJ
Biochem Pharmacol; 1992 Dec; 44(12):2289-95. PubMed ID: 1472094
[TBL] [Abstract][Full Text] [Related]
14. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--II. A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase.
Knox RJ; Friedlos F; Sherwood RF; Melton RG; Anlezark GM
Biochem Pharmacol; 1992 Dec; 44(12):2297-301. PubMed ID: 1472095
[TBL] [Abstract][Full Text] [Related]
15. The cumulative electrostatic effect of aromatic stacking interactions and the negative electrostatic environment of the flavin mononucleotide binding site is a major determinant of the reduction potential for the flavodoxin from Desulfovibrio vulgaris [Hildenborough].
Zhou Z; Swenson RP
Biochemistry; 1996 Dec; 35(50):15980-8. PubMed ID: 8973168
[TBL] [Abstract][Full Text] [Related]
16. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine.
Storici P; Capitani G; Müller R; Schirmer T; Jansonius JN
J Mol Biol; 1999 Jan; 285(1):297-309. PubMed ID: 9878407
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli.
Thoden JB; Frey PA; Holden HM
Biochemistry; 1996 Feb; 35(8):2557-66. PubMed ID: 8611559
[TBL] [Abstract][Full Text] [Related]
19. First-sphere and second-sphere electrostatic effects in the active site of a class mu gluthathione transferase.
Xiao G; Liu S; Ji X; Johnson WW; Chen J; Parsons JF; Stevens WJ; Gilliland GL; Armstrong RN
Biochemistry; 1996 Apr; 35(15):4753-65. PubMed ID: 8664265
[TBL] [Abstract][Full Text] [Related]
20. Crystallization and preliminary crystallographic data for an FMN-dependent nitroreductase from Escherichia coli B.
Skelly JV; Collins PJ; Knox RJ; Anlezark GM; Melton RG
J Mol Biol; 1994 May; 238(5):852-3. PubMed ID: 8182754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
